(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Clinical trial NCT02039726 · COMPLETED
Trial details
- NCT number
- NCT02039726
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2018-02-22
- Enrollment
- 367
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.